Home/Filings/4/0001639691-25-000029
4//SEC Filing

Bolton Stephanie 4

Accession 0001639691-25-000029

CIK 0001639691other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 9:01 PM ET

Size

36.2 KB

Accession

0001639691-25-000029

Insider Transaction Report

Form 4
Period: 2025-03-30
Bolton Stephanie
President, Global Epilepsy
Transactions
  • Award

    Performance Stock Units

    2025-03-30+7,0277,027 total
    Ordinary Shares (7,027 underlying)
  • Award

    Stock Appreciation Rights

    2025-03-30+15,38515,385 total
    Exercise: $39.13Exp: 2035-03-30Ordinary Shares (15,385 underlying)
  • Tax Payment

    Ordinary Shares

    2025-03-30$39.13/sh2,835$110,93412,751 total
  • Award

    Restricted Stock Units

    2025-03-30+7,0277,027 total
    Ordinary Shares (7,027 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-301,2293,686 total
    Ordinary Shares (1,229 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2025-03-308050 total
    Ordinary Shares (805 underlying)
  • Award

    Performance Stock Units

    2025-03-30+3,5133,513 total
    Ordinary Shares (3,513 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-304260 total
    Ordinary Shares (426 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2025-03-307170 total
    Ordinary Shares (717 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2025-03-301,0600 total
    Ordinary Shares (1,060 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-03-30+6,02415,586 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-30457457 total
    Ordinary Shares (457 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-301,3302,659 total
    Ordinary Shares (1,330 underlying)
  • Award

    Performance Stock Units

    2025-03-30+3,5133,513 total
    Ordinary Shares (3,513 underlying)
Footnotes (18)
  • [F1]Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.
  • [F10]On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired.
  • [F11]On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's Return on Investment Capital (ROIC) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The performance achieved was 78.5%, and the actual number of vested shares is presented as the quantity that was acquired.
  • [F12]On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 58%, and the actual number of vested shares is presented as the quantity that was acquired.
  • [F13]On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
  • [F14]Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.
  • [F15]On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's FCF for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
  • [F16]On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's ROIC calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
  • [F17]On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's TSR for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
  • [F18]On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
  • [F2]Shares withheld to satisfy tax liability.
  • [F3]Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.
  • [F4]On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.
  • [F5]On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.
  • [F6]Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.
  • [F7]On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
  • [F8]On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
  • [F9]Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement.

Issuer

LivaNova PLC

CIK 0001639691

Entity typeother

Related Parties

1
  • filerCIK 0002012558

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 9:01 PM ET
Size
36.2 KB